SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-11-001548
Filing Date
2011-02-28
Accepted
2011-02-28 16:40:44
Documents
10
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2202144z10-k.htm 10-K 1183520
2 EX-10.45 a2202144zex-10_45.htm EX-10.45 20491
3 EX-10.46 a2202144zex-10_46.htm EX-10.46 52959
4 EX-10.47 a2202144zex-10_47.htm EX-10.47 53037
5 EX-23.1 a2202144zex-23_1.htm EX-23.1 3060
6 EX-31.1 a2202144zex-31_1.htm EX-31.1 8113
7 EX-31.2 a2202144zex-31_2.htm EX-31.2 8126
8 EX-32 a2202144zex-32.htm EX-32 8897
9 G820672.JPG g820672.jpg GRAPHIC 99331
10 G974873.JPG g974873.jpg GRAPHIC 57955
  Complete submission text file 0001047469-11-001548.txt   1556679
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30319 | Film No.: 11646691
SIC: 2834 Pharmaceutical Preparations